| Primary |
| Product Used For Unknown Indication |
25.1% |
| Drug Use For Unknown Indication |
20.6% |
| Onychomycosis |
7.6% |
| Fungal Infection |
5.4% |
| Detoxification |
5.0% |
| Prophylaxis |
5.0% |
| Cushing's Syndrome |
3.4% |
| Drug Exposure During Pregnancy |
3.2% |
| Prostate Cancer |
3.2% |
| Fungal Skin Infection |
2.6% |
| Hypertension |
2.6% |
| Bronchitis |
2.4% |
| Tinea Versicolour |
2.4% |
| Vulvovaginal Candidiasis |
2.4% |
| Asthma |
1.6% |
| Diabetes Mellitus |
1.6% |
| Seborrhoeic Dermatitis |
1.6% |
| Candidiasis |
1.4% |
| Dandruff |
1.4% |
| Neoplasm Malignant |
1.4% |
|
| Drug Exposure During Pregnancy |
29.0% |
| Off Label Use |
7.6% |
| Vomiting |
6.9% |
| Pyrexia |
5.3% |
| Hepatic Function Abnormal |
4.6% |
| Jaundice |
4.6% |
| Rash |
3.8% |
| Wrong Technique In Drug Usage Process |
3.8% |
| International Normalised Ratio Increased |
3.1% |
| Overdose |
3.1% |
| Pain In Extremity |
3.1% |
| Pancytopenia |
3.1% |
| Product Counterfeit |
3.1% |
| Rhabdomyolysis |
3.1% |
| Trichorrhexis |
3.1% |
| Urticaria |
3.1% |
| Yellow Skin |
3.1% |
| Anaphylactic Reaction |
2.3% |
| Arrhythmia |
2.3% |
| Diabetes Mellitus |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
38.9% |
| Hypercorticoidism |
8.5% |
| Cushing's Syndrome |
5.2% |
| Asthma |
4.8% |
| Prophylaxis |
4.6% |
| Bronchitis |
4.3% |
| Detoxification |
4.3% |
| Drug Use For Unknown Indication |
3.3% |
| Onychomycosis |
3.0% |
| Supplementation Therapy |
2.6% |
| Blood Cholesterol |
2.2% |
| Depression |
2.2% |
| Osteoporosis |
2.2% |
| Pharyngitis |
2.2% |
| Acne |
2.0% |
| Candidiasis |
2.0% |
| Ear Infection |
2.0% |
| Hypothyroidism |
2.0% |
| Migraine |
2.0% |
| Sepsis |
2.0% |
|
| Off Label Use |
20.2% |
| Myoclonus |
10.7% |
| Death |
7.1% |
| Ear Discomfort |
6.0% |
| Hypoacusis |
6.0% |
| Pyrexia |
6.0% |
| Overdose |
4.8% |
| Trichorrhexis |
4.8% |
| Convulsion |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Product Counterfeit |
3.6% |
| Tremor |
3.6% |
| Wrong Technique In Drug Usage Process |
3.6% |
| Alopecia |
2.4% |
| Hepatic Encephalopathy |
2.4% |
| Hepatic Function Abnormal |
2.4% |
| Hepatitis |
2.4% |
| Intentional Drug Misuse |
2.4% |
| Lung Neoplasm Malignant |
2.4% |
| Pain In Extremity |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.9% |
| Psoriasis |
9.8% |
| Prophylaxis |
7.7% |
| Hypertension |
6.9% |
| Hiv Infection |
6.3% |
| Pain |
3.4% |
| Rheumatoid Arthritis |
3.3% |
| Eczema |
3.2% |
| Drug Use For Unknown Indication |
3.1% |
| Hepatitis C |
2.6% |
| Osteoporosis |
2.3% |
| Insomnia |
1.8% |
| Osteopenia |
1.8% |
| Asthma |
1.7% |
| Acne |
1.6% |
| Depression |
1.6% |
| Tinea Infection |
1.6% |
| Gastritis |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Cerebral Infarction |
1.3% |
|
| Weight Decreased |
12.3% |
| Wheezing |
8.4% |
| Pneumonia |
6.5% |
| Vomiting |
6.5% |
| Nausea |
5.8% |
| Pemphigoid |
5.2% |
| Renal Impairment |
5.2% |
| Rhabdomyolysis |
5.2% |
| Tooth Fracture |
5.2% |
| Vascular Graft |
5.2% |
| Fatigue |
4.5% |
| Decreased Appetite |
3.9% |
| Pyrexia |
3.9% |
| Rash |
3.9% |
| Scleroderma |
3.2% |
| Skin Ulcer |
3.2% |
| Somnolence |
3.2% |
| Tremor |
3.2% |
| Weight Increased |
3.2% |
| Acute Myocardial Infarction |
2.6% |
|
| Interacting |
| Antifungal Treatment |
50.0% |
| Lipids Increased |
50.0% |
|
|
